{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:23:04Z","timestamp":1772760184347,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.toxicon.2013.02.008","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T13:18:30Z","timestamp":1362575910000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American Rattlesnake bite patients"],"prefix":"10.1016","volume":"69","author":[{"given":"Sean P.","family":"Bush","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tammy H.","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R.","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen T.","family":"Reibling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2013.02.008_bib1","first-page":"518","article-title":"Clinical efficacy of two dosing regimens of affinity purified mixed monospecific crotalid antivenom ovine Fab","volume":"4","author":"Bogdan","year":"1997","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.toxicon.2013.02.008_bib2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/archinte.159.7.706","article-title":"Recurrent and persistent coagulopathy following viper envenomation","volume":"159","author":"Boyer","year":"1999","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.toxicon.2013.02.008_bib3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1067\/mem.2001.113134","article-title":"Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline Fab antivenom","volume":"37","author":"Boyer","year":"2001","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2013.02.008_bib4","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mem.2002.129939","article-title":"Crotalidae polyvalent immune fab (Ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri)","volume":"40","author":"Bush","year":"2002","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2013.02.008_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.toxicon.2012.04.244","article-title":"Continuous crotalidae polyvalent Fab(ovine) (FabAV) for selected snakebite patients [abstract]","volume":"60","author":"Bush","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.02.008_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1081\/CLT-200053339","article-title":"Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation","volume":"43","author":"Camilleria","year":"2005","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.toxicon.2013.02.008_bib7","unstructured":"CroFab\u00ae Crotalidae Polyvalent Immune Fab (Ovine) Package Insert:http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/FractionatedPlasmaProducts\/UCM117573.pdf."},{"key":"10.1016\/j.toxicon.2013.02.008_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0041-0101(94)90372-7","article-title":"Neurotoxicity, haemostatic disturbances and haemolytic anaemia after a bite by a Tunisian saw-scaled or carpet viper (Echis \u2018pyramidum\u2019-complex): failure of antivenom treatment","volume":"32","author":"Gillissen","year":"1994","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/j.toxicon.2013.02.008_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003088-200342080-00002","article-title":"Pharmacokinetic\u2013pharmacodynamic relationships of immunoglobulin therapy for envenomation","volume":"42","author":"Guti\u00e9rrez","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.toxicon.2013.02.008_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF03161198","article-title":"Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrination syndrome","volume":"4","author":"Kitchens","year":"2008","journal-title":"J. Med. Toxicol."},{"issue":"1","key":"10.1016\/j.toxicon.2013.02.008_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-3083.1978.tb00423.x","article-title":"Circulating immune complexes, complement activation kinetics and serum sickness following treatment with heterologous anti-snake venom globulin","volume":"7","author":"Nielsen","year":"1978","journal-title":"Scand. J. Immunol."},{"issue":"7","key":"10.1016\/j.toxicon.2013.02.008_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/PEC.0b013e3181ab7871","article-title":"Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation","volume":"25","author":"O'Brien","year":"2009","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.toxicon.2013.02.008_bib13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1542\/peds.110.5.968","article-title":"Crotaline fab antivenom for the treatment of children with rattlesnake envenomation","volume":"110","author":"Offerman","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.toxicon.2013.02.008_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00007611-199608000-00010","article-title":"Levels of therapeutic antivenin and venom in a human snakebite victim","volume":"89","author":"Ownby","year":"1996","journal-title":"South. Med. J."},{"issue":"1","key":"10.1016\/j.toxicon.2013.02.008_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.toxicon.2010.09.014","article-title":"Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom","volume":"57","author":"Ruha","year":"2011","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.toxicon.2013.02.008_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0196-0644(97)70110-0","article-title":"Relationship of venom effects to venom antigen and antivenom serum concentrations in a patient with Crotalus atrox envenomation treated with a Fab antivenom","volume":"30","author":"Seifert","year":"1997","journal-title":"Ann. Emerg. Med."},{"issue":"5","key":"10.1016\/j.toxicon.2013.02.008_bib17","first-page":"526","article-title":"Pharmacokinetic analysis of a crotalid Fab antivenom and theoretical consideration for the prevention of coagulopathic recurrence","volume":"36","author":"Seifert","year":"1998","journal-title":"Clin. Toxicol. (Phila)"},{"issue":"4","key":"10.1016\/j.toxicon.2013.02.008_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/15563650.2011.566883","article-title":"Recurrent, persistent, or late, new-onset hematologic abnormalities in crotaline snakebite","volume":"49","author":"Seifert","year":"2011","journal-title":"Clin. Toxicol. (Phila)"},{"issue":"5","key":"10.1016\/j.toxicon.2013.02.008_bib19","first-page":"747","article-title":"Recurrent hematologic abnormalities following antivenom (AV) therapy for crotaline snakebite","volume":"44","author":"Stanford","year":"2006","journal-title":"Clin. Toxicol. (Phila)"},{"issue":"4","key":"10.1016\/j.toxicon.2013.02.008_bib20","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.annemergmed.2006.07.773","article-title":"Crotaline snakebite management with fab antivenom in pediatric patients","volume":"48","author":"Stanford","year":"2006","journal-title":"Ann. Emerg. Med."},{"issue":"1","key":"10.1016\/j.toxicon.2013.02.008_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1553-2712.2010.00958.x","article-title":"Factors associated with difficulty achieving initial control with crotalidae polyvalent immune fab antivenom in snakebite patients","volume":"18","author":"Yin","year":"2011","journal-title":"Acad. Emerg. Med."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101011300069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101011300069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T07:31:46Z","timestamp":1539847906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004101011300069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":21,"alternative-id":["S004101011300069X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.02.008","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American Rattlesnake bite patients","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}